These studies suggest that TMPRSS4 could serve as a molecular target for anti-cancer therapy, and that inhibition of TMPRSS4 may have potential as a therapeutic strategy to reduce tumor growth and metastasis. The gene discussed is TMPRSS4; the disease is cancer.